Latest on Drug Hunter
-
Why Did Bristol Myers Squibb (BMS) Pay $4.1 Billion for Turning Point Therapeutics?
8 mins read •
6 days ago
Why Did Bristol Myers Squibb (BMS) Pay $4.1 Billion for Turning Point Therapeutics?
Turning Point Therapeutics ($TPTX) was recently acquired by BMS for a whopping $4.1 billion in cash. Turning Point’s most…
8 mins read
Top Premium Articles
-
Drug Discovery Technology Review: Emerging Tools and Modalities in 2022Q2/Q3
14 mins read •
2 months ago
Why Did GSK Pay $1.9B for Momelotinib, an Oral Ph. III Myelofibrosis Candidate?
6 mins read •
7 months ago
View All Premium Articles >
Drug Discovery Technology Review: Emerging Tools and Modalities in 2022Q1
10 mins read •
7 months ago
Join the Drug Hunter mailing list
to get free content and resources weekly. Trusted by > 5,500 drug hunters worldwide. Unsubscribe anytime.
Molecules of the Month
Drug Discovery Resources
- Drug Discovery Resources
- Drug Discovery Posters and Cheat Sheets
- Drug Discovery IPOs and Industry Reviews
- Lists of Approved Drugs
- Classics in Drug Discovery
- Drug Discovery Books
- Drug Discovery Conferences
- What is a Drug Hunter?
- Topliss Tree and Topliss Scheme Posters
- PK Reference Table / Cheat Sheet
- Pd-Couplings Table / Cheat Sheet
molecule of the day
AZD0364 – December
hall of fame: past molecules of the month
Check out previous entries below.
2022
2021
2020
past molecules of the year nominees
Check out previous nominees below.
past molecules of the year
Check out previous selections below.
Featured Reviewers
Join the Drug Hunter mailing list
to get free content and resources weekly. Trusted by > 5,500 drug hunters worldwide. Unsubscribe anytime.
Join Subscribers from
…and hundreds more!
